Market Overview

NOHO Licenses New FDA Formulation and Completes Asset Purchase with Greenfield Farms


PHOENIX, AZ / ACCESSWIRE / June 7, 2017 / NOHO, Inc. (OTC PINK: DRNK), a Wyoming corporation (the "Company"), announced the following:

FDA Formulation

The Company has executed a licensing agreement with DMR Biologics, LLC, of Schofield, Wisconsin, to acquire the exclusive rights to market and sell its homeopathic, FDA registered drug under the NOHO brand.

This new, lipid-based gel formulation is taken via a patented, sublingual (under the tongue) delivery method, contained in a small stick pack. The product offers fast and effective relief from Hangover pain and headache in bypassing the digestive system so it can be absorbed much faster than liquid or pill-based formulas. As a homeopathic medicine, it has no contraindicated drug interactions. The product's effectiveness is confirmed by two Double-blind/Placebo controlled clinical trials. Developed as a drug to treat migraine headaches, NOHO has contracted the exclusive rights to the product in the Hangover market. Most Hangover headaches are migranous in nature and there are numerous cross-over symptoms shared between migraine headaches and Hangovers.

David Mersky, NOHO's CEO stated, "Today, we are announcing that the company has acquired the exclusive rights to an FDA registered medicine that will be manufactured as a new NOHO product for the Hangover market. As an OTC drug, this new formulation will make NOHO the market leader in the Hangover space as the product is backed by two published clinical studies."

The company is in the process of obtaining a National Drug Code number and has secured financing to begin production of the new formulation within 30 days. Labeling and packaging designs will also be underway so that all approvals will be in place when the product is market ready in approximately 90 days. In addition to the formulation being clinically tested with great success, it is well-suited to both the retail and online markets, as it is small and light (a unit dose is 3ml) and can be easily carried by users or shipped in larger quantities at low cost.

"We are currently in negotiations for a large initial purchase order on the new product, which we hope to close while the initial run is in production. This new relationship will open the doors to the retail market and provide immediate revenue to the company. We'll be disclosing more details as we move ahead, but suffice it to say we're really excited by what's ahead for NOHO," said Mersky.

Greenfield Farms (GRAS)

The company, through Cherry Hill Financial, LLC, has completed the Asset Purchase Agreement with Greenfield Farms Food Inc. (OTC PINK: GRAS).

Pursuant to the deal, Cherry Hill's membership interest was acquired in exchange for 49% of GRAS' common stock. As the first of a series of anticipated transactions, the model places NOHO in control of the board of directors of the target.

The agreement requires GRAS to divest itself of its prior operations and bring in a new staff of licensed brokers and support personnel to begin marketing its pre-paid life insurance program to employees of staffing companies throughout the country. Ronald Heineman, GRAS' CEO will remain in place and rely on his years of experience in the staffing industry to access nearly 24,000 employees for enrollments.

The insurance program will pair employee bases with target companies under a co-employment relationship and offer employees life insurance as a 401(k) alternative, providing pre-paid coverage for up to three years.

David Mersky, NOHO, Inc.'s CEO, stated, "We have finally put all the pieces together to complete the acquisition of GRAS so we can begin to put the operations in place to start selling policies. It is a highly specialized and niche insurance offering that requires very particular components. We've got the secret sauce."

GRAS' shares will be booked corporately in NOHO's investment account.

For additional information on NOHO please visit and our full product site at and at, as well as at

Cautionary Note Regarding Forward-Looking Statements.

This press release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Noho, Inc. (the "Company"), its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words "may", "would", "will", "expect", "estimate", "can", "believe", "potential" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and actual results may differ materially from those projected in the forward looking statements as a result of various factors. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors that are disclosed under the heading "Risk Factors" and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities.

Investor/Media Contact:


View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at